Tech Company Financing Transactions
Genomind Funding Round
On 4/10/2014, Genomind raised $5 million in Series A investment from Claritas Capital and private investors.
Transaction Overview
Company Name
Announced On
4/10/2014
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Claritas Capital (Lead Investor) (Theresa Sexton)
Proceeds Purpose
We look forward to making the Genecept Assay more widely available to clinicians and their patients through this financing
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2200 Renaissance Blvd. 100
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Overview
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Koffler
Chief Financial Officer
Thomas Hess
Chief Information Officer
Jon Levine
Chief Medical Officer
David Krause
Chief Scientific Officer
Jay Lombard
Founder
Ronald Dozoretz
Vice President
David Robbins
Browse more venture capital transactions:
Prev: 4/10/2014: Mersana Therapeutics venture capital transaction
Next: 4/10/2014: Calient Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs